Star Imaging & Path Lab
BSE SMEOpen
BSE SMEOpen
IPO Closes in
--Days
--Hours
--Minutes
--Seconds
IPO Timeline
Issue open date
8 Aug 2025Issue close date
12 Aug 2025UPI mandate deadline
12 Aug 2025Allotment finalization
13 Aug 2025Refund initiation
14 Aug 2025Share credit
14 Aug 2025Listing date
18 Aug 2025Mandate end date
28 Aug 2025Lock-in end date for anchor investors (50%)
12 Sep 2025Lock-in end date for anchor investors (remaining)
11 Nov 2025IPO Closes in
--Days
--Hours
--Minutes
--Seconds
💸
IPO Subscription Status
| Category | Times | Allotment Chances |
|---|---|---|
| HNIs (Total) | 0.13 | 100% |
| bHNI | 0.15 | 100% |
| sHNI | 0.09 | 100% |
| QIBs | 0 | - |
| Retail | 0.05 | 100% |
Last updated: 8 August'25 04:25PM
Key Dates
Open
8 Aug 2025Close
12 Aug 2025Listing
18 Aug 2025Quick Stats
Issue Size:69cr
Lot Size:1000 shares
Issue Details
Issue Size:69cr
Offer for Sale:9,72,000 Shares
Face Value:₹10
Listing At:BSE SME
Reservation
50%
QIB
15%
NII
35%
Retail
Additional Resources
About the Company
Incorporated in 2004, Star Imaging and Path Lab is a healthcare diagnostics company providing a broad spectrum of medical testing services across multiple regions. The company operates with a dual focus on imaging and laboratory diagnostics, delivering comprehensive diagnostic solutions to both individual patients and healthcare institutions.
Strengths
- A comprehensive, integrated suite of diagnostic services, including pathology, radiology, cardiology, and neurology, all under one roof
- Operates across B2C, B2B, and B2G segments, providing a broad revenue base and market reach
- With a strong network and strategic expansion, Star Imaging ensures broad access to diagnostic services
- Experienced leadership with a strong track record in the diagnostic healthcare industry
- Continuous investment in advanced technology and strategic PPP engagement drive significant operational efficiencies
Risks
- Outstanding legal proceedings involving the company, directors, and promoters may impact cash flows and operations
- High reliance on Delhi & UP, makes the business vulnerable to regional disruptions
- Revenue concentration in pathology and radiology increases exposure to sector downturns
- Reliance on third-party vendors and institutional customers without long-term contracts
- Recent negative cash flows, high competition, and potential loss of leased premises could adversely affect the business
Star Imaging & Path Lab IPO – Frequently Asked Questions
- The price band for the Star Imaging & Path Lab IPO is set at ₹135 to ₹142 per share.
- The Star Imaging & Path Lab IPO opens on August 8, 2025 and closes on August 12, 2025.
- The tentative listing date for the Star Imaging & Path Lab IPO is August 18, 2025.
- You can apply for the Star Imaging & Path Lab IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Star Imaging & Path Lab, enter lot quantity and UPI ID, then approve the mandate.
- The lot size for the Star Imaging & Path Lab IPO is 1000 shares. Investors must apply for at least one lot (i.e., 1000 shares).